Invention Grant
- Patent Title: DNA vectors, transposons and transposases for eukaryotic genome modification
-
Application No.: US15287616Application Date: 2016-10-06
-
Publication No.: US10344285B2Publication Date: 2019-07-09
- Inventor: Jeremy Minshull , Mark Welch , Sridhar Govindrajan , Maggie Lee , Kate Caves , Jon Ness
- Applicant: DNA2.0, INC.
- Applicant Address: US CA Newark
- Assignee: DNA2.0, INC.
- Current Assignee: DNA2.0, INC.
- Current Assignee Address: US CA Newark
- Agency: Alston & Bird LLP
- Main IPC: C12N15/85
- IPC: C12N15/85 ; C12N15/67 ; C12N15/52 ; C12N15/81 ; C12N9/12 ; C12N15/62 ; C12R1/84 ; C12R1/865 ; C12N15/10 ; C12N15/63 ; C12N15/90

Abstract:
The present invention provides polynucleotide vectors for high expression of heterologous genes. Some vectors further comprise novel transposons and transposases that further improve expression. Further disclosed are vectors that can be used in a gene transfer system for stably introducing nucleic acids into the DNA of a cell. The gene transfer systems can be used in methods, for example, gene expression, bioprocessing, gene therapy, insertional mutagenesis, or gene discovery.
Public/Granted literature
- US20170101646A1 DNA VECTORS, TRANSPOSONS AND TRANSPOSASES FOR EUKARYOTIC GENOME MODIFICATION Public/Granted day:2017-04-13
Information query
IPC分类: